TMC310911, a novel human immunodeficiency virus type 1 protease inhibitor, shows in vitro an improved resistance profile and higher genetic barrier to resistance compared with current protease inhibitors.
Antimicrob Agents Chemother
; 55(12): 5723-31, 2011 Dec.
Article
en En
| MEDLINE
| ID: mdl-21896904
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Infecciones por VIH
/
Proteasa del VIH
/
VIH-1
/
Inhibidores de la Proteasa del VIH
/
Farmacorresistencia Viral
Límite:
Humans
Idioma:
En
Año:
2011
Tipo del documento:
Article